Biotage AB (publ) – disclosure notice of substantial holding of shares

Biotage AB (publ) has on 30 June 2010 bought back 56,000 shares. The Company`s aggregated holding of own shares thereby amounts to 4,441,987 shares, corresponding to 5.02 percent of the total amount of shares and votes in the Company. 

The total amount of shares outstanding, including shares held in treasury, amounts to 88,486,320.

Contact:                                  
Torben Jörgensen, President and CEO                
Tel: +46 707 49 05 84, torben.jorgensen@biotage.com 

Biotage discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at CET 8.30 am on 1 July 2010.

About Biotage
Biotage offers solutions, knowledge and experience in the areas of analytical chemistry and medicinal chemistry. The customers include the world’s largest pharmaceutical and biotech companies, and leading academic institutes. The company is headquartered in Uppsala and has subsidiaries in the US, UK and Japan. Biotage has 245 employees and had sales of 394.1 MSEK in 2009. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website: www.biotage.com